Clinical and immunological improvement in HIV-infected patients receiving iimuthiolR — A randomized, double blind, placebo-controlled trial
✍ Scribed by J.M. Lang; J.L. Touraine; C. Trepo; P. Choutet; M. Kirstetter; J. Caraux
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 71 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0192-0561
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess the efficacy and safety of pramipexole, a dopamine 3 receptor agonist, in patients with fibromyalgia. ## Methods In this 14‐week, single‐center, double‐blind, placebo‐controlled, parallel‐group, escalating‐dose trial, 60 patients with fibromyalgia were randomiz
## Abstract ## Objective To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). ## Methods This pilot study was a 12‐week randomized, double‐blind, placebo‐controlled trial of etanercept, with 14 subjects in each group. Patients received 25 mg of e
Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception. The aim of this double-blind, randomized, placebo-controlled trial was to study the effect of gabapentin on the